• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Immun Inflamm Dis . Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection

tetano

Editor, Senior Moderator
Immun Inflamm Dis


. 2022 Dec;10(12):e733.
doi: 10.1002/iid3.733.
Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection


Yan Wu[SUP] 1 [/SUP], Yiyin Long[SUP] 2 [/SUP], Feng Wang[SUP] 3 [/SUP], Wei Liu[SUP] 4 [/SUP], Yuliang Wang[SUP] 2 [/SUP]



Affiliations

Abstract

Introduction: Nowadays, emerging SARS-CoV-2 Omicron, the novel highly mutated VOC, has quickly spread as the dominant variant in over 190 countries worldwide through the first part of 2022, which is influencing the infectivity, transmissibility, pathogenicity, and severity of COVID-19 pandemic. Additionally, clinical cases and experimental studies have reported that Omicron variant likely leads to weakened immune protection elicited by infection, antibody therapies, and vaccines. The new wave, from late February, 2022, was escalated abruptly by higher levels of transmission of Omicron BA.2 sublineage in China.
Methods and results: Following a systematic database search, this review summarizes the salient features of Omicron sublineages, and their impact on transmissibility, disease severity as well as the efficacy of the available vaccines and treatment against the Omicron.
Conclusion: We hope this study will provide a scientific reference for alleviating the burden of COVID-19.

Keywords: Omicron; mutations; severe acute respiratory syndrome coronavirus 2; transmissibility; vaccination.
 
Back
Top Bottom